Bevacizumab treatment for choroidal neovascularization due to age-related macular degeneration in Japanese patients.
about
Effectiveness of intravitreal ranibizumab in exudative age-related macular degeneration (AMD): comparison between typical neovascular AMD and polypoidal choroidal vasculopathy over a 1 year follow-up.Efficacy and safety of intravitreal aflibercept injection in wet age-related macular degeneration: outcomes in the Japanese subgroup of the VIEW 2 study.Two-year outcomes of pro re nata ranibizumab monotherapy for exudative age-related macular degeneration in Japanese patients.Early responses to intravitreal ranibizumab in typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.Novel automated screening of age-related macular degeneration.
P2860
Bevacizumab treatment for choroidal neovascularization due to age-related macular degeneration in Japanese patients.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Bevacizumab treatment for chor ...... neration in Japanese patients.
@en
Bevacizumab treatment for chor ...... neration in Japanese patients.
@nl
type
label
Bevacizumab treatment for chor ...... neration in Japanese patients.
@en
Bevacizumab treatment for chor ...... neration in Japanese patients.
@nl
prefLabel
Bevacizumab treatment for chor ...... neration in Japanese patients.
@en
Bevacizumab treatment for chor ...... neration in Japanese patients.
@nl
P2093
P1476
Bevacizumab treatment for chor ...... eneration in Japanese patients
@en
P2093
Hirokazu Sakaguchi
Mihoko Suzuki
Motokazu Tsujikawa
P2888
P304
P356
10.1007/S10384-009-0775-3
P50
P577
2010-03-01T00:00:00Z